Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$26,395,695
-$5,824,938 QoQ
Shares Held
42,332
+1.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
#5
of 109 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 99.95275441746196.ToString("F0")%
Shared 0.ToString("F0")%
None 0.047245582538032696.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ATWOOD & PALMER INC holds $54,515,898 across 9 Biotechnology names. REGN ranks #2 (48.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,357 | $27,994,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
42,332 | $26,395,695 | |
| 3 | GALT |
Galectin Therapeutics Inc
|
10,000 | $46,400 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
1,400 | $25,158 | |
| 5 | EXEL |
Exelixis, Inc.
|
395 | $21,491 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,000 | $17,400 | |
| 7 | MNKD |
Mannkind Corp
|
2,000 | $8,520 | |
| 8 | MRNA |
Moderna, Inc.
|
100 | $7,003 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,395,695 | 42,332 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $32,220,633 | 41,702 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $32,277,287 | 41,817 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $23,295,408 | 41,431 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $21,833,700 | 41,588 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $26,621,170 | 41,974 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $31,116,711 | 43,683 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $46,044,312 | 43,800 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $46,097,124 | 43,859 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $42,289,885 | 43,938 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $39,061,069 | 44,474 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $37,300,662 | 45,325 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $32,675,606 | 45,475 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $34,577,516 | 42,082 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $30,296,808 | 41,992 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $28,871,230 | 41,911 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $24,521,254 | 41,482 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $28,670,839 | 41,051 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $25,738,229 | 40,756 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $17,127,804 | 28,302 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $15,737,423 | 28,176 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $70,971 | 150 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $48,311 | 100 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $41,983 | 75 | Shares | Sole | 2020-10-28 | |
| No filing history on record for this holder in this stock. | ||||||